ELOBP3

Across TCGA pan-cancer cohorts, ELOBP3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ELOBP3’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where ELOBP3 RNA is repressed in tumor relative to normal tissue. In most cancer types ELOBP3 is over-expressed in tumor, although a few such as BLCA and STAD show the opposite, repressed pattern.

BLCA, STAD, and READ are the cancer types where ELOBP3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELOBP3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	III,IV	−0.417	.013	6	view →
STAD	All	All	−0.175	.008	2	view →
READ	Female	All	−0.184	.046	1	view →
THCA	Female	All	−0.034	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

ELOBP3–BLCA

Open the BLCA breakdown →